MedPath

Post-traumatic dysfunction of the innate and adaptive immune system and its relationship with the development of infectious complications in severely injured patients (POSEIDON study)

Completed
Conditions
blood poisoning
sepsis
10004018
10047954
10027665
Registration Number
NL-OMON53029
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1. Severely injured trauma patients based on the following criteria:
- Severe injury (e.g. AIS > 3) in at least 2 body regions
- Physiological disturbances on hospital admission based on:
* Heart rate > 100 beats/min, and/or
* Systolic blood pressure < 100 mmHg, and/or
* Base excess < -6 mmol/L, and/or
* pH < 7,20, and/or
* Hb < 5,5
2. Admission to the IMCU or ICU of the UMCU with an expected stay of at least
48 hours.
3. Age: 18 - 80 years
4. Informed consent (when proxy consent is obtained and the patient leaves the
IMCU/ICU in good mental health, personal informed consent is additionally
necessary)

Exclusion Criteria

- Immunosuppressive medication
- Known HIV positive status and related diseases

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The difference in (anti-bacterial) characteristics of circulating neutrophils<br /><br>between trauma patients who develop sepsis and non-septic patients.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- The difference in (anti-bacterial) characteristics of circulating neutrophils<br /><br>between trauma patients who develop infectious complications other than sepsis<br /><br>(e.g. pneumonia, meningitis, urinary tract infections, pericarditis, abdominal<br /><br>abscesses, wound infections and fracture related infections) and non-infectious<br /><br>patients.<br /><br>- The difference in (anti-bacterial) characteristics of circulating neutrophils<br /><br>between trauma patients who develop pro-inflammatory complications (e.g. SIRS)<br /><br>and patients who don't develop these complications.<br /><br>- The difference in (inducible) activation status of neutrophils between<br /><br>patients with and without infectious or inflammatory complications</p><br>
© Copyright 2025. All Rights Reserved by MedPath